معرفی
Dr. Christina Boucher is an Associate Professor in the Department of Computer and Information Science and Engineering at the University of Florida. Her research focuses on bioinformatics, with a particular emphasis on developing algorithms and software for genomic data analysis, antimicrobial resistance monitoring, and metagenomics. She is known for her contributions to succinct data structures and alignment methods, and her work on tools like MEGARes and AMRPlusPlus has significantly impacted antibiotic resistance classification. Dr. Boucher holds a Ph.D. from the University of Waterloo, where she was supported by prestigious awards including the Google Anita Borg Memorial Scholarship and NSERC Fellowships.
Her research interests span computational genomics, algorithm design, and software development for high-throughput sequencing. She has pioneered methods for pangenome indexing, long-read haplotype reconstruction, and portable metagenomics analysis. Dr. Boucher actively promotes diversity in bioinformatics through her roles on committees such as the NSF Research Traineeships Program advisory board and the University of Florida’s Implicit Bias committee.
- Key Awards: ESA 2016 Best Paper Award, NSERC Doctoral Award, Google Anita Borg Memorial Scholarship
- Software Contributions: MEGARes, AMRPlusPlus, METAMarc, Moni
- Professional Roles: NIH BDMA Study Section Standing Member, Board Member of SIG BIO
Dr. Boucher’s publications reflect a blend of algorithmic innovation and applied genomic research. Recent work addresses challenges in portable sequencing device security, resistome-mobilome colocalization detection, and high-accuracy assembly polishing. Her interdisciplinary collaborations span microbiology, veterinary medicine, and clinical sciences, underscoring the translational impact of her computational approaches.
Her teaching and mentorship efforts focus on curriculum development and fostering inclusive environments in STEM. She has been a key figure in advancing computational tools for antimicrobial resistance monitoring and has contributed to NIH-funded initiatives aimed at improving antibiotic therapy through causal modeling techniques.
